ResearcherConsejo Nacional de Investigaciones Científicas y TécnicasActive in the last 2 years

Ramiro Héctor Cerviño

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5064328594. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2024: 1 paper

Papers 1

Flurbiprofen inhibits cAMP transport by MRP4/ABCC4 increasing the potency of gemcitabine treatment in PDAC cell models. Co-author DOI 10.1016/j.ijbiomac.2024.136386 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Ana Sahores · 1 shared paper, 2024 · strength 0.23
- Paper Flurbiprofen inhibits cAMP transport by MRP4/ABCC4 increasing the potency of gemcitabine treatment in PDAC cell models. DOI 10.1016/j.ijbiomac.2024.136386 ↗
Betina González · 1 shared paper, 2024 · strength 0.23
- Paper Flurbiprofen inhibits cAMP transport by MRP4/ABCC4 increasing the potency of gemcitabine treatment in PDAC cell models. DOI 10.1016/j.ijbiomac.2024.136386 ↗
Carlos Alberto Davio · 1 shared paper, 2024 · strength 0.23
- Paper Flurbiprofen inhibits cAMP transport by MRP4/ABCC4 increasing the potency of gemcitabine treatment in PDAC cell models. DOI 10.1016/j.ijbiomac.2024.136386 ↗
Agustín Yaneff · 1 shared paper, 2024 · strength 0.23
- Paper Flurbiprofen inhibits cAMP transport by MRP4/ABCC4 increasing the potency of gemcitabine treatment in PDAC cell models. DOI 10.1016/j.ijbiomac.2024.136386 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.